The alteration of unique spectral markers in the serum may be an important diagnostic tool for the future early confident detection of RA in combination with other existing criteria such as X-ray images highlighting erosions, auto-antibody titres and non-specific markers of inflammation (ESR and CRP). This evidence concerns the gene CRP and rheumatoid arthritis.